The Vista 120 supports adult, paediatric and neonatal patients in a variety of care environments – including Intensive Care, Operating Rooms, Emergency Departments and Neonatal Intensive Care. Medibus/Medibus-X connectivity enables the Vista 120 to be used with a complementary Dräger device, such as a ventilator or anaesthesia machine allowing true integrated workstation functionality.
The Vista 120 displays up to 13 waveforms in an easy-to-configure layout and offers a core set of essential parameters including 3/5 lead ECG, non-invasive blood pressure, respiration and dual temperature. Advanced parameters including three invasive blood pressures, flexible mainstream and sidestream etCO2 and cardiac output are also available.
Users can add external parameter modules including SCIO, CO2 and BIS on model C and model C+ after initial device purchase.
The Vista 120 is easy to learn and easy to use. You can configure the display to see the information you want to see, the way you want to see it. Fast access keys and simplified menus put the data you need right at your fingertips.
The Vista 120 offers BISx measurement to support clinicians with enhanced information as they monitor the depth of anesthesia. It allows the ability to better assess patient status and quickly respond to a changing condition.
The Vista 120 provides seamless connectivity to Dräger Scio anaesthetic gas measurement modules delivering precise inspiratory and expiratory values.
The Vista 120 offers direct connection to the hospital information system (HIS) and/or an electronic medical record in HL7 protocol or a secure connection via the Vista 120 Gateway. The ability for easy access to both of these important information files help improve workflow efficiency and reduce human error.
Every life is unique. Protecting, supporting and saving lives is the foundation of our company philosophy. Our goal is to provide product and solutions that support acute care, help improve patient outcomes, reduce costs and achieve greater overall patient satisfaction.